ArticleHaematologica2022

A clinical practice comparison of patients with chronic lymphocytic leukemia with and without deletion 17p receiving first-line treatment with ibrutinib.

Anthony R Mato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.